Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 18;27(18):6093.
doi: 10.3390/molecules27186093.

A Label-Free Fluorescence Aptasensor Based on G-Quadruplex/Thioflavin T Complex for the Detection of Trypsin

Affiliations

A Label-Free Fluorescence Aptasensor Based on G-Quadruplex/Thioflavin T Complex for the Detection of Trypsin

Pan Gu et al. Molecules. .

Abstract

A novel, label-free fluorescent assay has been developed for the detection of trypsin by using thioflavin T as a fluorescent probe. A specific DNA aptamer can be combined by adding cytochrome c. Trypsin hydrolyzes the cytochrome c into small peptide fragments, exposing the G-quadruplex part of DNA aptamer, which has a high affinity for thioflavin T, which then enhances the fluorescence intensity. In the absence of trypsin, the fluorescence intensity was inhibited as the combination of cytochrome c and the DNA aptamer impeded thioflavin T's binding. Thus, the fluorescent biosensor showed a linear relationship from 0.2 to 60 μg/mL with a detection limit of 0.2 μg/mL. Furthermore, the proposed method was also successfully employed for determining trypsin in biological samples. This method is simple, rapid, cheap, and selective and possesses great potential for the detection of trypsin in bioanalytical and biological samples and medical diagnoses.

Keywords: DNA aptamer; cytochrome c; label-free; thioflavin T; trypsin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic illustration of the fluorometric assay for detecting trypsin.
Figure 2
Figure 2
Feasibility of the proposed method: Fluorescence intensity of DNA aptamer-ThT; DNA aptamer-ThT with and without adding trypsin. All reactions were performed in 50 mmol/L Tris and 1 mmol/L KCl buffer at pH 7.5. In total, 50 μmol/L DNA aptamer, 1 mmol/L ThT, 10 mmol/L cyt c, 10 mg/mL trypsin, and 30 min of incubation time were employed. Fluorescence intensity was measured using an F-2700 with excitation at 490 nm, and the emission spectra were collected in the range of 450 to 550 nm.
Figure 3
Figure 3
Optimizing the experimental conditions: (a) concentration of different experimental components, including DNA chain (1 mM ThT, 10 mM cyt c, and 10 mg/mL trypsin; 30 min of incubation time and a different concentration of DNA aptamer were employed), cytochrome c (250 nM DNA aptamer, 1 mM ThT, and 10 mg/mL trypsin; 30 min of incubation time and a different concentration of cyt c were employed), and ThT (250 nM DNA aptamer, 80 μM cyt c, and 10 mg/mL trypsin; 30 min of incubation time and a different concentration of ThT were employed); (b) reaction time for trypsin and cytochrome c (250 nM DNA aptamer and 80 μM cyt c with or without 10 mg/mL trypsin incubated within a different time range and then 10 μM ThT added for testing) and reaction time for the DNA chain (250 nM DNA aptamer with or without 80 μM cyt c incubated within a different time range and then 10 μM ThT added for testing).
Figure 4
Figure 4
(a) Fluorescence emission spectra upon addition of trypsin at different concentrations, from 0 to 140 μg/mL. (b) Fluorescence signal in response to different concentrations of trypsin, showing the linear curve of the enhanced fluorescence intensity to the concentration of trypsin. The inset shows the linearity of the fluorescence intensity with respect to trypsin concentrations.
Figure 5
Figure 5
Selectivity of the assay. Selectivity of the proposed trypsin assay toward trypsin, HSA, GSH, Actin, PKA, ALP, and thrombin (60 μg/mL each).

Similar articles

Cited by

References

    1. Atkinson M.A., Campbell-Thompson M., Kusmartseva I., Kaestner K.H. Organisation of the human pancreas in health and in diabetes. Diabetologia. 2020;63:1966–1973. doi: 10.1007/s00125-020-05203-7. - DOI - PMC - PubMed
    1. Sensoy I. A review on the food digestion in the digestive tract and the used in vitro models. Curr. Res. Food Sci. 2021;4:308–319. doi: 10.1016/j.crfs.2021.04.004. - DOI - PMC - PubMed
    1. Hegyi E., Tóth A.Z., Vincze Á., Szentesi A., Hegyi P., Sahin-Tóth M. Alcohol-dependent effect of PRSS1-PRSS2 haplotype in chronic pancreatitis. Gut. 2020;69:1713–1715. doi: 10.1136/gutjnl-2019-319729. - DOI - PMC - PubMed
    1. Hirota M., Ohmuraya M., Hashimoto D., Suyama K., Sugita H., Ogawa M. Roles of Autophagy and Pancreatic Secretory Trypsin Inhibitor in Trypsinogen Activation in Acute Pancreatitis. Pancreas. 2020;49:493–497. doi: 10.1097/MPA.0000000000001519. - DOI - PubMed
    1. Lasher D., Szabó A., Masamune A., Chen J.M., Xiao X., Whitcomb D.C., Barmada M.M., Ewers M., Ruffert C., Paliwal S., et al. Protease-Sensitive Pancreatic Lipase Variants Are Associated With Early Onset Chronic Pancreatitis. Am. J. Gastroenterol. 2019;114:974–983. doi: 10.14309/ajg.0000000000000051. - DOI - PMC - PubMed

LinkOut - more resources